Publications by authors named "Ute Essner"

Claim this Profile
P
Patient-reported benefits from nabiximols treatment in multiple sclerosis-related spasticity exceed conventional measures.
Michael R Haupts, Ute Essner, Mathias Mäurer

Neurodegener Dis Manag· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Sativex on cognitive function in patients with multiple sclerosis: A systematic review and meta-analysis.
Igor Dykukha, Ute Essner, Herbert Schreiber, Lina Marie Raithel, Iris-Katharina Penner

Mult Scler Relat Disord· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety/tolerability of pridinol: a meta-analysis of double-blind, randomized, placebo-controlled trials in adult patients with muscle pain.
Michael A Überall, Ute Essner, Gerhard H H Müller-Schwefe

Curr Med Res Opin· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness, Safety, and Tolerability of Nabiximols Oromucosal Spray vs Typical Oral Long-Acting Opioid Analgesics in Patients with Severe Neuropathic Back Pain: Analysis of 6-Month Real-World Data from the German Pain e-Registry.
Michael A Ueberall, Carlos Vila Silván, Ute Essner, Gerhard H H Mueller-Schwefe

Pain Med· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the Effectiveness and Tolerability of Nabiximols (THC:CBD) Oromucosal Spray versus Oral Dronabinol (THC) as Add-on Treatment for Severe Neuropathic Pain in Real-World Clinical Practice: Retrospective Analysis of the German Pain e-Registry.
Michael A Ueberall, Ute Essner, Carlos Vila Silván, Gerhard H H Mueller-Schwefe

J Pain Res· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of drug-induced constipation and severity of associated biopsychosocial effects in patients with nonmalignant pain: a cross-sectional review of depersonalized data from the German Pain e-Registry.
Michael A Ueberall, Ute Essner, Gerhard Müller-Schwefe, Johannes Horlemann, Martin Storr

Curr Med Res Opin· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nabiximols in Chronic Neuropathic Pain: A Meta-Analysis of Randomized Placebo-Controlled Trials.
Igor Dykukha, Rolf Malessa, Ute Essner, Michael A Überall

Pain Med· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tetrahydrocannabinol and cannabidiol oromucosal spray in resistant multiple sclerosis spasticity: consistency of response across subgroups from the SAVANT randomized clinical trial.
Sven G Meuth, Thomas Henze, Ute Essner, Christiane Trompke, Carlos Vila Silván

Int J Neurosci· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and tolerability of THC:CBD oromucosal spray as add-on measure in patients with severe chronic pain: analysis of 12-week open-label real-world data provided by the German Pain e-Registry.
Michael A Ueberall, Ute Essner, Gerhard Hh Mueller-Schwefe

J Pain Res· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Daily Practice Managing Resistant Multiple Sclerosis Spasticity With Delta-9-Tetrahydrocannabinol: Cannabidiol Oromucosal Spray: A Systematic Review of Observational Studies.
Katja Akgün, Ute Essner, Cordula Seydel, Tjalf Ziemssen

J Cent Nerv Syst Dis· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sativex as add-on therapy vs. further optimized first-line ANTispastics (SAVANT) in resistant multiple sclerosis spasticity: a double-blind, placebo-controlled randomised clinical trial.
Jolana Markovà, Ute Essner, Bülent Akmaz, Marcella Marinelli, Christiane Trompke

Int J Neurosci· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, tolerability, and safety of an oral enzyme combination vs diclofenac in osteoarthritis of the knee: results of an individual patient-level pooled reanalysis of data from six randomized controlled trials.
Michael A Ueberall, Gerhard Hh Mueller-Schwefe, Rainer Wigand, Ute Essner

J Pain Res· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Burden of disease in multiple sclerosis patients with spasticity in Germany: mobility improvement study (Move I).
Uwe K Zettl, Thomas Henze, Ute Essner, Peter Flachenecker

Eur J Health Econ· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Memantine (Ebixa) in clinical practice - results of an observational study.
Pasquale Calabrese, Ute Essner, Hans Forstl

Dement Geriatr Cogn Disord· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis